LY-215840

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

LY-215,840 is an ergoline and lysergamide derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT 2 and 5-HT 7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.

LY-215,840 is an ergoline and lysergamide derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT 2 and 5-HT 7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.

See also

Substituted lysergamide

References

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370484677 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.